T Beynon1,2, L Selman2, E Radcliffe2, S Whittaker3, F Child3, D Orlowska3, C Morgans3, S Morris4, R Harding2. 1. Department of Palliative Care, South Wing Block B 2nd floor, St Thomas' Hospital, SE1 7EH, London, U.K. 2. Department of Palliative Care, Policy and Rehabilitation, Kings College London, London, U.K. 3. St John's Institute of Dermatology, St Thomas' Hospital, SE1 7EH, London, U.K. 4. Department of Clinical Oncology, Guys and St Thomas' Hospital, London, U.K.
Abstract
BACKGROUND: Primary cutaneous T-cell lymphoma (CTCL) is a rare but prevalent condition which can have a significant impact on many aspects of quality of life. However, there is little evidence of patients' lived experience of CTCL. OBJECTIVES: To understand in greater depth patients' experiences of living and coping with CTCL, and to inform the development of models of care for this population in line with U.K. METHODS: Semi-structured interviews were conducted with a purposive sample of patients with CTCL who attended an inner-city teaching hospital. Participants were purposively selected according to their disease stage, age, sex and ethnicity. RESULTS: Nineteen patients with CTCL (stages IB-IVB), aged between 41 and 83 years, participated in a single interview. This included 10 men; 15 people identified themselves as white British. Interviews lasted a median of 55 (range 28-170) min. Two main themes emerged: issues regarding diagnosis, particularly a perceived delay in diagnosis, and the impact of CTCL (subthemes related to physical well-being, practical concerns and psychological and social well-being and coping). CONCLUSIONS: Findings from this study illuminate the diverse effects of CTCL on patients' lives. The universal experience of delays in diagnosis was striking and a concern to patients. The disease, particularly its physical symptoms, had a significant impact on patients' lives, including employment, leisure and relationships. Despite the symptom burden and its impact, participants described effective coping strategies such as drawing on social support, maintaining normal lives and becoming well informed about CTCL. Proactive holistic assessment and management of the range of patient concerns is needed in providing care for patients with CTCL and their family and friends.
BACKGROUND:Primary cutaneous T-cell lymphoma (CTCL) is a rare but prevalent condition which can have a significant impact on many aspects of quality of life. However, there is little evidence of patients' lived experience of CTCL. OBJECTIVES: To understand in greater depth patients' experiences of living and coping with CTCL, and to inform the development of models of care for this population in line with U.K. METHODS: Semi-structured interviews were conducted with a purposive sample of patients with CTCL who attended an inner-city teaching hospital. Participants were purposively selected according to their disease stage, age, sex and ethnicity. RESULTS: Nineteen patients with CTCL (stages IB-IVB), aged between 41 and 83 years, participated in a single interview. This included 10 men; 15 people identified themselves as white British. Interviews lasted a median of 55 (range 28-170) min. Two main themes emerged: issues regarding diagnosis, particularly a perceived delay in diagnosis, and the impact of CTCL (subthemes related to physical well-being, practical concerns and psychological and social well-being and coping). CONCLUSIONS: Findings from this study illuminate the diverse effects of CTCL on patients' lives. The universal experience of delays in diagnosis was striking and a concern to patients. The disease, particularly its physical symptoms, had a significant impact on patients' lives, including employment, leisure and relationships. Despite the symptom burden and its impact, participants described effective coping strategies such as drawing on social support, maintaining normal lives and becoming well informed about CTCL. Proactive holistic assessment and management of the range of patient concerns is needed in providing care for patients with CTCL and their family and friends.
Authors: Lillian Chen; Jackelyn B Payne; Kaylin V Dance; Conner B Imbody; Cathy D Ho; Amy A Ayers; Christopher R Flowers Journal: Clin Lymphoma Myeloma Leuk Date: 2019-10-19
Authors: Jennifer A Salant; Niloufer Khan; Judith E Nelson; Moe Norton-Westbrook; Anjali V Desai Journal: J Palliat Med Date: 2021-12-31 Impact factor: 2.947
Authors: Joy Tao; Courtney Hentz; Michael L Mysz; Issra Rashed; David Eilers; James Swan; Rebecca Tung; Bahman Emami Journal: Case Rep Dermatol Med Date: 2018-08-07
Authors: Edgar Dippel; Chalid Assaf; Jürgen C Becker; Michael von Bergwelt-Baildon; Sophie Bernreiter; Antonio Cozzio; Hans T Eich; Khaled Elsayad; Markus Follmann; Stephan Grabbe; Uwe Hillen; Wolfram Klapper; Claus-Detlev Klemke; Carmen Loquai; Frank Meiss; Christina Mitteldorf; Ulrike Wehkamp; Dorothee Nashan; Jan P Nicolay; Ilske Oschlies; Max Schlaak; René Stranzenbach; Rose Moritz; Christoph Stoll; Tibor Vag; Michael Weichenthal; Marion Wobser; Rudolf Stadler Journal: J Dtsch Dermatol Ges Date: 2022-04 Impact factor: 5.231
Authors: R Ottevanger; S van Beugen; A W M Evers; R Willemze; M H Vermeer; K D Quint Journal: J Eur Acad Dermatol Venereol Date: 2021-08-14 Impact factor: 9.228
Authors: T S Bhat; C M Herbosa; A R Rosenberg; O Sogade; D B Jeffe; N Mehta-Shah; Y R Semenov; A C Musiek Journal: Br J Dermatol Date: 2020-08-02 Impact factor: 9.302